Thanks for visiting my page, Welcome!

Support Angela!
Olga's Butterflies "SURVIVOR" Team team page
No Badges Have Been Earned

100 percent of goal achieved.

Mme./Mrs. Angela Evangeliou

Goal: $1,250.00
Achieved: $1,251.00


Donate to my journey and make this Weekend matter! 

Pharmaprix(MD) Weekend to End Women's Cancers? is a 2-day, 60-kilometre or 1-day 32-kilometre walk through the neighbourhoods of Montreal. It's going to be a challenge, but I'm ready to do something bold and powerful in effort to end women's cancers once and for all. 

My commitment is based on love for my fellow sisters, mothers, grandmas, daughters, nieces, and friends everywhere. It's based on the realization that we each need to do our part in this fight. I can walk. I can raise funds to benefit the Segal Cancer Centre at the Jewish General Hospital - a leader in the fight against all women's cancers. I can and choose to be a part of this movement to take down women's cancers!

I ask you to take a stance with me and join this life-saving adventure for all women. Be a part of my very personal journey - by giving, by walking with me, or simply by sharing my story with your circle of influence. Don't stand back and think about what you could have done ? take that first step today! Take a chance with me - we have the opportunity to change thousands of lives, beginning with our own.  

This isn't just my journey - it's yours, too.
Make it a Weekend you'll never forget. 


Cancer statistics at a glance

Cancer statistics tell us how many people in Canada are diagnosed with and die from cancer each year. They show us the trends in new cases and cancer deaths. Cancer statistics also tell us the likelihood of surviving a cancer diagnosis and the number of people who are alive after a cancer diagnosis.


Canadian provinces and territories collect data on cancer cases and cancer deaths. These data are combined to provide a picture of the impact of cancer for all of Canada.


Statistics are an important part of planning and measuring the success of cancer control.

Incidence and mortality

Incidence is the total number of new cases of cancer. Mortality is the number of deaths due to cancer. To provide the most current cancer statistics, researchers use statistical methods to estimate the number of new cancer cases and deaths until actual data become available.


An estimated 186,400 new cases of cancer and 75,700 deaths from cancer will occur in Canada in 2012. (The number of estimated new cases does not include 81,300 new non-melanoma skin cancer cases.)


Cancer is the leading cause of death in Canada and is responsible for about 30% of all deaths.



It is estimated that in 2012:

  • 97,600 Canadian men will be diagnosed with cancer and 39,500 men will die from cancer.
  • 88,800 Canadian women will be diagnosed with cancer and 36,200 women will die from cancer.
  • On average, over 500 Canadians will be diagnosed with cancer every day.
  • On average, over 200 Canadians will die from cancer every day.



Lung, prostate, breast and colorectal cancer are the most common types of cancer in Canada (excluding non-melanoma skin cancer). Based on 2012 estimates:

  • These cancers account for over half (54%) of all new cancer cases.
  • Prostate cancer accounts for about one-quarter (27%) of all new cancer cases in men.
  • Lung cancer accounts for 14% of all new cases of cancer.
  • Breast cancer accounts for about one-quarter (26%) of all new cancer cases in women.
  • Colorectal cancer accounts for 13% of all new cancer cases.


Trends in cancer rates

Cancer is a disease that mostly affects Canadians aged 50 and older, but it can occur at any age.


Across Canada, cancer incidence rates vary because of differences in the type of population, risk factors (including risk behaviours) and early detection practices. Similarly, rates of cancer death vary because cancer screening rates and the availability and use of treatment vary across the country.

Chances (probability) of developing or dying from cancer

Based on 2006 estimates:

  • 2 out of 5 Canadians (45% of men and 40% of women) are expected to develop cancer during their lifetimes.
  • 1 out of 4 Canadians (29% of men and 24% of women) is expected to die from cancer.



Prevalence is the total number of people living with a diagnosis of cancer at a certain point in time. This statistic can be useful in planning healthcare services for people recently diagnosed with cancer and for cancer survivors.


In 2007, about 749,000 Canadians diagnosed with cancer in the previous 10 years were alive. This represents about 2.3% of the Canadian population or 1 out of every 44 Canadians.


The number of newly diagnosed cancer cases in Canada is increasing, but survival rates are also increasing. These improved survival rates account for the growing number of Canadian cancer survivors.


Survival is the percentage of people who are alive at some point in time after their cancer diagnosis. There are many different ways of measuring and reporting cancer survival statistics. Most survival statistics are reported for a specific time period, such as 5 years.

  • Survival rates vary from low to high depending on the type of cancer and other factors. For example, based on 2004-2006 estimates:
    • The 5-year relative survival rate for lung cancer is low (16%).
    • The 5-year relative survival rate for colorectal cancer is average (63%).
    • The 5-year relative survival rate is high for prostate cancer (96%) and breast cancer (88%).
  • Based on 2004-2006 estimates, 62% of Canadians diagnosed with cancer are expected to survive for 5 years or more after a cancer diagnosis.
  • Between 1992-1994 and 2004-2006, survival rates increased from 56% to 62% for all cancers combined.



Note: For 2012 the population of Canada is estimated to be 34,922,000.


For more information, go to Canadian Cancer Statistics.






Print & Mail Donation Form

My Participant ID: 475331-7

<script type="text/javascript" src=""></script><script type="text/javascript">stLight.options({publisher:'4722e868-614f-43c0-b5ee-a22d5ff217c0'});</script>

<span class="st_facebook_large" displayText="Facebook"></span><span class="st_twitter_large" displayText="Tweet"></span><span class="st_email_large" displayText="Email"></span><span class="st_sharethis_large" displayText="ShareThis"></span>

If you think this page contains objectionable content, please inform the system administrator.